Defining the impact of hemophilia: the Academic Achievement in Children with Hemophilia Study.
about
Potential role of a new PEGylated recombinant factor VIII for hemophilia A.Treatment of haemophilia A and B and von Willebrand's disease: summary and conclusions of a systematic review as part of a Swedish health-technology assessment.A global view on prophylaxis: possibilities and consequences.Quality of life assessment in haemophilia.Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN).International workshop on immune tolerance induction: consensus recommendations.Optimizing outcomes for patients with severe haemophilia A.Antihemophilic factor (recombinant) plasma/albumin-free method for the management and prevention of bleeding episodes in patients with hemophilia AExploration of the pathogenesis of haemophilic joint arthropathy: understanding implications for optimal clinical management.Haemophilia prophylaxis: how can we justify the costs?Development of long-acting recombinant FVIII and FIX Fc fusion proteins for the management of hemophilia.A systematic review and quantitative analysis of neurocognitive outcomes in children with four chronic illnesses.The burden of bleeding in haemophilia: is one bleed too many?Understanding the experience of caring for children with haemophilia: cross-sectional study of caregivers in the United States.Considerations in individualizing prophylaxis in patients with haemophilia A.Current management of the hemophilic child: a demanding interlocutor. Quality of life and adequate cost-efficacy analysis.Prevention of bleeding in hemophilia patients with high-titer inhibitors.Comparative burden of arthropathy in mild haemophilia: a register-based study in Sweden.Psychosocial care for children with haemophilia and their parents in the Netherlands.Quantifying adherence to treatment and its relationship to quality of life in a well-characterized haemophilia population.Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia.VERITAS-Pro: a new measure of adherence to prophylactic regimens in haemophilia.Considerations in the evaluation of haemophilia patients for short-term prophylactic therapy: a paediatric and adult case study.Unresolved issues in prophylaxis.Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors.Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study.Prophylaxis in the haemophilia population-optimizing therapy.Why is primary prophylaxis underutilized in the United States?Frequency and causes of hospitalization in HIV-negative children and adolescents with haemophilia A or B and its effect on academic achievement.The economic impact of factor VIII inhibitors in patients with haemophilia.Assessment of healthcare measures, healthcare resource use, and cost of care among severe hemophilia A patients in Mumbai region of India.Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A.The impact of social factors on outcomes in patients with bleeding disorders.Telehealth Videoconferencing for Children With Hemophilia and Their Families: A Clinical Project.Changing pattern of care of boys with haemophilia in western European centres.Haemophilia-related morbidity and quality-of-life.Is education causally related to better health? A twin fixed-effect study in the USA.Validation of the Brazilian version of the VERITAS-Pro scale to assess adherence to prophylactic regimens in hemophilia.
P2860
Q26744309-C89098CF-2C34-46F6-9256-B5BC9B74D1F7Q34094037-30DE118B-951C-4BB9-926A-EB719593731BQ35112430-F3FEEA76-4871-4C96-AC53-FAFF67E80721Q35677000-D5CC6F05-5C24-49D4-966C-6BA57F580D0FQ35887945-9648B228-CC46-49B1-8DA6-1CDFA87BFF06Q36861097-9E1A62FE-3354-4F05-A2EC-E7254139F580Q36932769-E65363C2-FC7A-4DCA-A956-57929F2C4C38Q37303186-6CEF91E1-D065-43B9-BF6E-15D09BE73E9EQ37952373-20ED526F-14CF-4086-8239-BD088C7C22A8Q38002994-BD9385EA-4DDD-49CF-9343-EEE6F5C95E0FQ38127745-D8D6863C-ED3F-4E92-B7C0-F2FE4747CB9CQ38137261-E4C1FC6C-8343-489B-8642-7D40298CE887Q38182702-CD1720DD-5221-4B5C-8FF1-7D0055C9DB23Q38182706-A8531AB7-015F-4780-B6B2-39D610E7BFB4Q38203021-AFB61939-7483-4DED-81D2-3651E0612B15Q38227605-AA5821EE-5CFB-4FDC-9A76-86424516AA94Q38456352-4276B68D-B3FD-4D23-9CDE-776954CC6CF9Q38982572-6051612C-7EB2-405E-8CAC-7574E52D5ABAQ39189320-A67F70F4-975D-49F6-B0DD-3FCBB3882BE9Q40172564-479B3B33-0A65-4921-8B30-08C3C1A38CB6Q42293158-682AF294-E5A5-452F-AF69-BD62B2AE9124Q44125442-B286C299-B9DD-40F8-A79F-1FAD1DCCFF27Q45855111-672663D4-338F-46AC-A956-D6604289480EQ45856040-98918A35-351A-4A7C-B23A-BD8784D3F207Q45856086-1994170C-6CA7-4D62-8A25-37D46A16123AQ45858388-6EAFE6BA-E7A3-44A9-B240-F05C391B6634Q45868025-247AD6E1-5214-4747-8583-5C55B7D987E2Q45872046-6E119F9E-4A94-4AF7-9FF8-DC9AC726F40AQ45872722-91630120-6497-4978-9A59-C07160D18CA4Q45872737-5A9B8725-EB0C-4D8C-8C01-78D826BA324FQ45873585-F3158A6C-E52E-4F28-9180-353053CF2DFDQ45877719-0F18F879-5A61-4FB3-A614-B48E00D893E6Q45878025-F68E512B-B0CC-4F55-8B0C-8F126142A868Q45880279-BBC440A3-69C8-4584-8F23-2B743F7173B4Q45882439-EBAA82E8-7FE3-4CBC-BD78-94A8C10F775EQ45885020-90711961-E5BE-4CCC-B244-E46837722283Q51631923-1D61BDE7-93D1-431D-B854-0A02D9A3C8BAQ55389077-509C2033-0F97-41C0-873D-97AD85E8C399
P2860
Defining the impact of hemophilia: the Academic Achievement in Children with Hemophilia Study.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Defining the impact of hemophi ...... hildren with Hemophilia Study.
@ast
Defining the impact of hemophi ...... hildren with Hemophilia Study.
@en
Defining the impact of hemophi ...... hildren with Hemophilia Study.
@nl
type
label
Defining the impact of hemophi ...... hildren with Hemophilia Study.
@ast
Defining the impact of hemophi ...... hildren with Hemophilia Study.
@en
Defining the impact of hemophi ...... hildren with Hemophilia Study.
@nl
prefLabel
Defining the impact of hemophi ...... hildren with Hemophilia Study.
@ast
Defining the impact of hemophi ...... hildren with Hemophilia Study.
@en
Defining the impact of hemophi ...... hildren with Hemophilia Study.
@nl
P2093
P356
P1433
P1476
Defining the impact of hemophi ...... hildren with Hemophilia Study.
@en
P2093
A D Shapiro
Academic Achievement in Children with Hemophilia Study Group
E D Gomperts
J A Stehbens
S L Hunsberger
S M Donfield
P356
10.1542/PEDS.108.6.E105
P407
P577
2001-12-01T00:00:00Z